“…In our portfolio experience, CP‐03504992 and CP‐642,931, but not its pharmacological pair, CP‐470,711, promoted cholesterol domain formation in rat brain sphingomyelin membranes (data not shown), suggesting disruptions on proper cholesterol biosynthesis and cholesterol domain formation as important independent contributors to cataract formation, which is a known feature of cataractous lenses (Jacob et al, ). Other known cataractogens such as U18666A and 1,2‐naphthoquinone, the reactive metabolite of naphthalene, also promote cholesterol domain formation through oxidative stress (Cenedella, ; Cenedella et al, ; Jacob, Aleo, Self‐Medlin, Doshna, & Mason, ).…”